4FVD image
Deposition Date 2012-06-29
Release Date 2013-06-19
Last Version Date 2024-11-13
Entry Detail
PDB ID:
4FVD
Title:
Crystal structure of EV71 2A proteinase C110A mutant in complex with substrate
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.66 Å
R-Value Free:
0.22
R-Value Work:
0.18
R-Value Observed:
0.19
Space Group:
C 1 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:2A proteinase
Mutations:C110A
Chain IDs:A
Chain Length:152
Number of Molecules:1
Biological Source:Human enterovirus 71
Polymer Type:polypeptide(L)
Molecule:10-mer peptide from 2A proteinase
Chain IDs:B (auth: C)
Chain Length:10
Number of Molecules:1
Biological Source:Human enterovirus 71
Ligand Molecules
Primary Citation
Conformational Plasticity of 2A Proteinase from Enterovirus 71
J.Virol. 87 7348 7356 (2013)
PMID: 23616646 DOI: 10.1128/JVI.03541-12

Abstact

The 2A proteinase (2A(pro)) is an enterovirally encoded cysteine protease that plays essential roles in both the processing of viral precursor polyprotein and the hijacking of host cell translation and other processes in the virus life cycle. Crystallographic studies of 2A(pro) from enterovirus 71 (EV71) and its interaction with the substrate are reported here. EV71 2A(pro) was comprised of an N-terminal domain of a four-stranded antiparallel β sheet and a C-terminal domain of a six-stranded antiparallel β barrel with a tightly bound zinc atom. Unlike in other 2A(pro) structures, there is an open cleft across the surface of the protein in an open conformation. As demonstrated by the crystallographic studies and modeling of the complex structure, the open cleft could be fitted with the substrate. On comparison 2A(pro) of EV71 to those of the human rhinovirus 2 and coxsackievirus B4, the open conformation could be closed with a hinge motion in the bII2 and cII β strands. This was supported by molecular dynamic simulation. The structural variation among different 2A(pro) structures indicates a conformational flexibility in the substrate-binding cleft. The open structure provides an accessible framework for the design and development of therapeutics against the viral target.

Legend

Protein

Chemical

Disease

Primary Citation of related structures